ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 142 filers reported holding ANACOR PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.00 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $8,977,000 | -61.8% | 167,953 | -19.2% | 0.02% | -63.6% |
| Q4 2015 | $23,489,000 | +43.7% | 207,919 | +49.8% | 0.04% | +33.3% |
| Q3 2015 | $16,342,000 | +252.4% | 138,832 | +131.8% | 0.03% | +266.7% |
| Q2 2015 | $4,638,000 | +70.8% | 59,898 | +27.6% | 0.01% | +80.0% |
| Q1 2015 | $2,715,000 | +82.0% | 46,932 | +1.4% | 0.01% | +66.7% |
| Q4 2014 | $1,492,000 | +31.8% | 46,264 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $1,132,000 | +38.0% | 46,264 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $820,000 | +11.6% | 46,264 | +26.0% | 0.00% | 0.0% |
| Q1 2014 | $735,000 | +20.5% | 36,719 | +1.0% | 0.00% | +100.0% |
| Q4 2013 | $610,000 | – | 36,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 5,621,423 | $59,700,000 | 36.62% |
| VHCP Management, LLC | 1,610,856 | $17,107,000 | 9.45% |
| Broadfin Capital, LLC | 1,737,669 | $18,454,000 | 3.28% |
| Consonance Capital Management LP | 737,685 | $7,834,000 | 1.96% |
| Palo Alto Investors LP | 1,600,178 | $16,994,000 | 1.78% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 520,091 | $5,523,000 | 1.06% |
| QVT Financial LP | 1,358,303 | $14,425,000 | 0.98% |
| Lombard Odier Asset Management (USA) Corp | 1,700,000 | $18,054,000 | 0.91% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,702,300 | $18,061,000 | 0.89% |
| Perceptive Advisors | 1,947,736 | $20,684,000 | 0.85% |